A novel flow-perfusion bioreactor supports 3D dynamic cell culture

Stephen M. Warren, Alexander M. Sailon, Alexander C. Allori, Edward H. Davidson, Derek D. Reformat, Robert J. Allen

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background. Bone engineering requires thicker three-dimensional constructs than the maximum thickness supported by standard cell-culture techniques (2mm). A flow-perfusion bioreactor was developed to provide chemotransportation to thick (6mm) scaffolds. Methods. Polyurethane scaffolds, seeded with murine preosteoblasts, were loaded into a novel bioreactor. Control scaffolds remained in static culture. Samples were harvested at days 2, 4, 6, and 8 and analyzed for cellular distribution, viability, metabolic activity, and density at the periphery and core. Results. By day 8, static scaffolds had a periphery cell density of 67±5.0, while in the core it was 0.3±0.3. Flow-perfused scaffolds demonstrated peripheral cell density of 94±8.3 and core density of 76±3.1 at day 8. Conclusions. Flow perfusion provides chemotransportation to thick scaffolds. This system may permit high throughput study of 3D tissues in vitro and enable prefabrication of biological constructs large enough to solve clinical problems.

Original languageEnglish (US)
Article number873816
JournalJournal of Biomedicine and Biotechnology
Volume2009
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Bioreactors
Cell culture
Scaffolds
Cell Culture Techniques
Perfusion
Cell Count
Polyurethanes
Bone and Bones
Bone
Throughput
Tissue
In Vitro Techniques

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Health, Toxicology and Mutagenesis

Cite this

A novel flow-perfusion bioreactor supports 3D dynamic cell culture. / Warren, Stephen M.; Sailon, Alexander M.; Allori, Alexander C.; Davidson, Edward H.; Reformat, Derek D.; Allen, Robert J.

In: Journal of Biomedicine and Biotechnology, Vol. 2009, 873816, 01.12.2009.

Research output: Contribution to journalArticle

Warren, Stephen M. ; Sailon, Alexander M. ; Allori, Alexander C. ; Davidson, Edward H. ; Reformat, Derek D. ; Allen, Robert J. / A novel flow-perfusion bioreactor supports 3D dynamic cell culture. In: Journal of Biomedicine and Biotechnology. 2009 ; Vol. 2009.
@article{d010869d459c47d784f906a65a42ba8a,
title = "A novel flow-perfusion bioreactor supports 3D dynamic cell culture",
abstract = "Background. Bone engineering requires thicker three-dimensional constructs than the maximum thickness supported by standard cell-culture techniques (2mm). A flow-perfusion bioreactor was developed to provide chemotransportation to thick (6mm) scaffolds. Methods. Polyurethane scaffolds, seeded with murine preosteoblasts, were loaded into a novel bioreactor. Control scaffolds remained in static culture. Samples were harvested at days 2, 4, 6, and 8 and analyzed for cellular distribution, viability, metabolic activity, and density at the periphery and core. Results. By day 8, static scaffolds had a periphery cell density of 67±5.0, while in the core it was 0.3±0.3. Flow-perfused scaffolds demonstrated peripheral cell density of 94±8.3 and core density of 76±3.1 at day 8. Conclusions. Flow perfusion provides chemotransportation to thick scaffolds. This system may permit high throughput study of 3D tissues in vitro and enable prefabrication of biological constructs large enough to solve clinical problems.",
author = "Warren, {Stephen M.} and Sailon, {Alexander M.} and Allori, {Alexander C.} and Davidson, {Edward H.} and Reformat, {Derek D.} and Allen, {Robert J.}",
year = "2009",
month = "12",
day = "1",
doi = "10.1155/2009/873816",
language = "English (US)",
volume = "2009",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - A novel flow-perfusion bioreactor supports 3D dynamic cell culture

AU - Warren, Stephen M.

AU - Sailon, Alexander M.

AU - Allori, Alexander C.

AU - Davidson, Edward H.

AU - Reformat, Derek D.

AU - Allen, Robert J.

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Background. Bone engineering requires thicker three-dimensional constructs than the maximum thickness supported by standard cell-culture techniques (2mm). A flow-perfusion bioreactor was developed to provide chemotransportation to thick (6mm) scaffolds. Methods. Polyurethane scaffolds, seeded with murine preosteoblasts, were loaded into a novel bioreactor. Control scaffolds remained in static culture. Samples were harvested at days 2, 4, 6, and 8 and analyzed for cellular distribution, viability, metabolic activity, and density at the periphery and core. Results. By day 8, static scaffolds had a periphery cell density of 67±5.0, while in the core it was 0.3±0.3. Flow-perfused scaffolds demonstrated peripheral cell density of 94±8.3 and core density of 76±3.1 at day 8. Conclusions. Flow perfusion provides chemotransportation to thick scaffolds. This system may permit high throughput study of 3D tissues in vitro and enable prefabrication of biological constructs large enough to solve clinical problems.

AB - Background. Bone engineering requires thicker three-dimensional constructs than the maximum thickness supported by standard cell-culture techniques (2mm). A flow-perfusion bioreactor was developed to provide chemotransportation to thick (6mm) scaffolds. Methods. Polyurethane scaffolds, seeded with murine preosteoblasts, were loaded into a novel bioreactor. Control scaffolds remained in static culture. Samples were harvested at days 2, 4, 6, and 8 and analyzed for cellular distribution, viability, metabolic activity, and density at the periphery and core. Results. By day 8, static scaffolds had a periphery cell density of 67±5.0, while in the core it was 0.3±0.3. Flow-perfused scaffolds demonstrated peripheral cell density of 94±8.3 and core density of 76±3.1 at day 8. Conclusions. Flow perfusion provides chemotransportation to thick scaffolds. This system may permit high throughput study of 3D tissues in vitro and enable prefabrication of biological constructs large enough to solve clinical problems.

UR - http://www.scopus.com/inward/record.url?scp=73449106780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449106780&partnerID=8YFLogxK

U2 - 10.1155/2009/873816

DO - 10.1155/2009/873816

M3 - Article

C2 - 20037739

AN - SCOPUS:73449106780

VL - 2009

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 873816

ER -